What Is Driving the Growth of the Global Interventional Radiology Market?

The global interventional radiology market has experienced tremendous growth, driven by rising demand for minimally invasive diagnostic and therapeutic procedures. Valued at USD 24.20 billion in 2024, the market is projected to reach USD 46.29 billion by 2034, growing at a CAGR of 6.70% during 2025–2034.

This growth is underpinned by advancements in medical imaging technologies, an increasing prevalence of chronic diseases such as cardiovascular disorders and cancer, and a global shift toward less invasive treatment options that offer faster recovery times and lower healthcare costs.

Interventional radiology combines image-guided procedures using X-ray, MRI, CT, and ultrasound technologies to diagnose and treat a range of medical conditions with precision and minimal trauma to the patient.

Market Overview: The Shift Toward Minimally Invasive Healthcare

The growing adoption of interventional radiology techniques across hospitals and clinics reflects a broader trend toward patient-centered, minimally invasive care. These procedures are replacing traditional surgeries due to their reduced pain, shorter hospital stays, and lower risk of complications.

Advancements in robotic imaging, AI integration, and high-resolution modalities are further expanding the clinical applications of interventional radiology, from cardiovascular interventions to targeted cancer therapies.

Key benefits of interventional radiology include:

• Reduced recovery time and hospital stay

• Enhanced diagnostic accuracy

• Lower procedural risks and costs

• Wider applicability across multiple specialties

Global Interventional Radiology Market Size and Share

• Market Value (2024): USD 24.20 Billion

• Forecast (2034): USD 46.29 Billion

• CAGR (2025–2034): 6.70%

The market is witnessing strong demand from cardiology, oncology, and gastroenterology applications, driven by rising chronic disease incidence and the need for real-time image-guided precision therapies.

North America dominates the global interventional radiology market due to advanced healthcare infrastructure, high adoption of imaging systems, and growing investments in diagnostic innovations. However, Asia Pacific is expected to record the fastest growth, supported by rising healthcare expenditure, expanding hospital networks, and increased awareness of early diagnosis.

Key Trends Shaping the Interventional Radiology Market

• Integration of Artificial Intelligence (AI) and Machine Learning (ML)
  AI-enhanced imaging systems are improving the accuracy of diagnostic interpretations, helping clinicians detect abnormalities faster and with higher precision.

• Growing Demand for Outpatient and Ambulatory Procedures
  The rise of ambulatory surgical centers (ASCs) offering same-day procedures at lower costs is boosting demand for portable and compact interventional radiology systems.

• Increasing Prevalence of Chronic Diseases
  Rising cases of cancer, cardiovascular diseases, and urological disorders are fueling the need for minimally invasive imaging-guided treatments.

• Technological Innovations in Imaging Devices
  Companies are investing in next-generation CT scanners, angiography systems, and biopsy devices that provide enhanced visualization and improved patient safety.

• Shift Toward Value-Based Care Models
  Hospitals are prioritizing solutions that improve efficiency, reduce costs, and enhance patient outcomes—factors strongly aligned with interventional radiology solutions.

Market Analysis by Product

The market is segmented by product type into:

• MRI Systems – Critical for detecting soft tissue abnormalities and guiding interventional procedures.

• CT Scanners – Widely used for real-time imaging in minimally invasive surgeries.

• Ultrasound Imaging Systems – Preferred for dynamic imaging in obstetrics, cardiology, and oncology.

• Angiography Systems – Essential for vascular imaging and interventional cardiology.

• Biopsy Devices – Increasing use in oncology for guided tissue sampling.

• Fluoroscopy Systems – Enable continuous X-ray imaging during procedures.

• Others – Including hybrid imaging modalities and support equipment.

Market Analysis by Technology

• Catheters – Most widely used tools for delivering therapies directly to target areas.

• Stents – Used extensively in vascular and cardiac interventions.

• Inferior Vena Cava (IVC) Filters – Deployed to prevent pulmonary embolism.

• Hemodynamic Flow Alteration (HFA) Devices – Assist in restoring normal blood flow.

• Angioplasty Balloons – Expand narrowed arteries and improve blood circulation.

• Thrombectomy Systems – Used for removing blood clots in stroke or DVT patients.

• Embolization Devices – Block abnormal blood flow, particularly in tumor management.

• Biopsy Needles – Enable precision-guided tissue sampling.

• Accessories and Others – Include guidewires and imaging agents.

These technologies have significantly improved treatment outcomes, offering safer and faster alternatives to open surgical procedures.

Market Analysis by Procedure

• Angioplasty:
  One of the most common procedures for widening blocked arteries using balloons or stents.

• Angiography:
  Involves imaging of blood vessels to diagnose vascular abnormalities.

• Embolization:
  Used to block abnormal blood flow in cases such as aneurysms and tumors.

• Thrombolysis:
  Dissolves dangerous blood clots to prevent stroke or heart attack.

• Biopsy and Drainage:
  Minimally invasive sampling and fluid removal under image guidance.

• Vertebroplasty:
  Treats spinal compression fractures by injecting bone cement into vertebrae.

• Nephrostomy and Other Procedures:
  Involve kidney drainage and targeted interventions for organ-specific conditions.

Market Analysis by Application

• Cardiology:
  Dominates the interventional radiology market due to the high incidence of cardiovascular diseases and increasing adoption of minimally invasive angioplasty and stenting.

• Urology and Nephrology:
  Growing usage in kidney stone removal and nephrostomy procedures.

• Oncology:
  Rapid growth driven by the adoption of image-guided tumor embolization and biopsy.

• Gastroenterology:
  Used for drainage, stenting, and feeding tube placements.

• Obstetrics and Others:
  Imaging for fetal and maternal health monitoring and procedural interventions.

Market Analysis by End User

• Hospitals:
  Represent the largest end-user segment due to the presence of advanced imaging infrastructure and skilled radiologists.

• Clinics:
  Increasing adoption of portable and cost-effective imaging systems.

• Ambulatory Surgical Centres:
  Fastest-growing segment as ASCs offer convenience, cost efficiency, and quick recovery times.

• Others:
  Includes diagnostic laboratories and specialized imaging centers.

Regional Insights

• North America:
  Leads the global market due to high healthcare expenditure, technological innovation, and early adoption of digital imaging systems.

• Europe:
  Strong presence of global manufacturers and increasing use of interventional techniques in chronic disease management.

• Asia Pacific:
  Expected to grow fastest owing to improved healthcare access, growing medical tourism, and government support for advanced medical technology adoption.

• Latin America:
  Steady growth due to increasing hospital infrastructure and healthcare reforms.

• Middle East and Africa:
  Expanding diagnostic capabilities and investment in healthcare modernization are supporting market expansion.

Key Players in the Interventional Radiology Market

• General Electric

• Koninklijke Philips N.V.

• Carestream Health

• Hitachi, Ltd.

• Hologic, Inc.

• Shimadzu Corporation

• Siemens Healthcare GmbH

• Canon Medical Systems Corporation

• Samsung Medison Co., Ltd.

• Medtronic Plc

• Agfa-Gevaert Group

• Teleflex Incorporated

• Analogic Corporation

• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

• Trivitron Healthcare

• Stryker Corporation

• Olympus Corporation

• Toshiba Medical Systems

These companies focus on AI-driven imaging solutions, product innovation, strategic acquisitions, and R&D investment to expand their portfolios and strengthen their global footprint.

Market Growth Drivers

• Increasing prevalence of chronic diseases such as cancer and cardiovascular disorders

• Rising adoption of minimally invasive procedures

• Continuous technological advancements in imaging systems

• Growth in ambulatory surgical centers and outpatient care

• Favorable reimbursement policies and government support

Recent Developments and Challenges

Recent Developments

• Siemens Healthcare GmbH introduced next-generation angiography systems with AI integration.

• GE HealthCare launched advanced MRI and CT platforms optimized for interventional applications.

• Medtronic Plc expanded its image-guided therapy portfolio through new acquisitions.

Challenges

• High installation and maintenance costs of imaging systems.

• Shortage of skilled interventional radiologists in developing regions.

• Stringent regulatory approval processes for advanced technologies.

Future Outlook

The future of interventional radiology lies in precision medicine, AI integration, and robotic-assisted procedures. As the technology evolves, image-guided interventions will become even safer, faster, and more accurate—paving the way for widespread adoption across global healthcare systems.

Key Opportunities:

• AI-based imaging analytics for better diagnostic insights.

• Expansion of interventional oncology and cardiology segments.

• Miniaturization of imaging devices for portable and home-based applications.

View More Reports

Nanopore Sequencing Market

Osteoporosis Drug Pipeline Analysis Report

India Disposable Medical Gloves Market

CDMO Market Size

About Us:

Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.

Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.

Media Contact:

Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com